Overview

A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders

Status:
Unknown status

Trial end date:
2014-06-01

Target enrollment:

Participant gender:

Summary

This trial designed to investigate the effect of switching to aripiprazole from risperidone or paliperidone on reverse prolactin level, and consequently improve sexual dysfunction in adult patients with schizophrenia spectrum disorders and bipolar spectrum disorders.

Phase:

Phase 4

Details

Lead Sponsor:

Si Tianmei

Treatments:

Aripiprazole
Paliperidone Palmitate
Risperidone